Related references
Note: Only part of the references are listed.Metformin Action: Concentrations Matter
Ling He et al.
CELL METABOLISM (2015)
Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network
Clemence D. Cote et al.
NATURE MEDICINE (2015)
Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats
Frank A. Duca et al.
NATURE MEDICINE (2015)
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis:of 11 randomized controlled trials
Kai Liu et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity
Hayley M. O'Neill et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Russell A. Miller et al.
NATURE (2013)
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
Morgan D. Fullerton et al.
NATURE MEDICINE (2013)
SIRTUIN 1 AND SIRTUIN 3: PHYSIOLOGICAL MODULATORS OF METABOLISM
Ruben Nogueiras et al.
PHYSIOLOGICAL REVIEWS (2012)
AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol
Jee-Hyun Um et al.
DIABETES (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Resveratrol improves health and survival of mice on a high-calorie diet
Joseph A. Baur et al.
NATURE (2006)
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
A Natali et al.
DIABETOLOGIA (2006)
Share Paper
